ECSP15026152A -
NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES WHICH HAVE ACTIVITY AS BETA2 ADRENERGIC AGONISTS AND AS MUSCARINIC M3 ANTAGONISTS
- Google Patents
NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES WHICH HAVE ACTIVITY AS BETA2 ADRENERGIC AGONISTS AND AS MUSCARINIC M3 ANTAGONISTS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frigocon Ind De Frio E Congelacao S AfiledCriticalFrigocon Ind De Frio E Congelacao S A
Publication of ECSP15026152ApublicationCriticalpatent/ECSP15026152A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La presente invención se refiere a nuevos compuestos que tienen doble actividad agonista Beta2 adrenérgica y antagonista muscarínica M3, a composiciones farmacéuticas que los contienen, al procedimiento para su preparación y a su uso en terapias de la vías respiratorias.The present invention relates to new compounds that have double beta2 adrenergic agonist and muscarinic M3 antagonist activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory tract therapies.
ECIEPI201526152A2012-12-182015-06-18
NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES WHICH HAVE ACTIVITY AS BETA2 ADRENERGIC AGONISTS AND AS MUSCARINIC M3 ANTAGONISTS
ECSP15026152A
(en)
Compounds derived from azabicyclo [3.2.1] octane; x fernesoid receptor agonist (fxr); process to prepare the compounds; intermediate compound; pharmaceutical composition and pharmaceutical combination that comprise a compound; and use of the compounds in the preparation of medicaments for the treatment of dyslipidemia.